Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF

Heistinger, Max; Stockenhuber, Felix; Schneider, Barbara; Pabinger, Ingrid; Brenner, Brigitte; Wagner, Brunhilde; Balcke, Peter; Lechner, Klaus; Kyrle, Paul A.
December 1990
Kidney International;Dec1990, Vol. 38 Issue 6, p1181
Academic Journal
In a double-blind, randomized, placebo-controlled cross-over study, we investigated in seven patients with chronic renal failure the effect of conjugated estrogens (0.6 mg/kg/day for 5 days) on template bleeding time and on thromboxane A2 (TxA2), β-thromboglobulin (β-TG) and prostacyclin (PGI2) concentrations in blood emerging from the template bleeding time incisions. Administration of conjugated estrogens resulted in a significant shortening of the bleeding time in six out of seven patients with a maximum effect 7 and/or 14 days following treatment. Both TxA2 (measured as thromboxane B2, TxB2) and β-TG release in bleeding time blood were significantly higher following administration of conjugated estrogens as compared to placebo administration. No difference was seen in endothelial PGI2 (measured as 6-keto-prostaglandin F1α) formation when patients were treated with conjugated estrogens as compared to placebo administration over the 28 day observation period. We conclude that in patients with chronic renal failure, infusion of conjugated estrogens results in a significant shortening of the bleeding time together with an increase in platelet reactivity, as indicated by an increase of TxA2 and β-TG concentration in the microvasculature. No effect was seen on PGI2 production, thereby excluding a major effect on vascular prostaglandin metabolism.


Related Articles

  • Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. Rodrigue, Marie-Ève; Lacasse-M, Sonia; Larivière, Richard; Lebel, Marcel // Canadian Journal of Physiology & Pharmacology;Jun2005, Vol. 83 Issue 6, p467 

    We previously reported that thromboxane (TX)A2 synthesis and receptor blockade prevented recombinant human erythropoietin (rhEPO)-induced hypertension in chronic renal failure rats. The present study was designed to investigate the effect of a cyclooxygenase inhibitor, acetylsalicylic acid...

  • Chronic Renal Failure and Hypothyroidism. Singh, Vivek; Rai, Yogesh Kumar; Kem, Anil Kumar // Indian Journal of Public Health Research & Development;Jan-Mar2012, Vol. 3 Issue 1, p174 

    This study was undertaken to test the thyroid function with chronic renal failure. Forty patients of CRF and forty healthy who served as control were studied for their thyroid function status. The study observed low total T3 and total T4 values in clinically euthyroid CRF patients. However,...

  • Insulin release from pancreatic islets: Effects of CRF and excess PTH. Fadda, George Z.; Akmal, Mohammad; Premdas, Francis H.; Lipson, Loren G.; Massry, Shaul G. // Kidney International;Jun1988, Vol. 33 Issue 6, p1066 

    Insulin secretion may be impaired in chronic renal failure (CRF) and available data suggest that this abnormality may be related to the state of secondary hyperparathyroidism of renal failure. We directly measured insulin release from isolated islets of Langerhans obtained from normal rats,...

  • Quantitative characteristics of calcitonin-producing cells in the thyroid and lungs of uremic rats. Kasacka, Irena // Folia Histochemica et Cytobiologica;2008, Vol. 46 Issue 4, p525 

    Uremia leads to a number of metabolic and hormonal disorders induced by renal failure with definite biological and clinical sequels. For this reason and the absence of reports on influence of CRF on calcitonin (CT)-producing cells of the thyroid glands and airways, the author decided to...

  • Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression. Bruggeman, Leslie A.; Pellicoro, Jill A.; Horigan, Elizabeth A.; Klotman, Paul E. // Kidney International;Jun1993, Vol. 43 Issue 6, p1219 

    Alterations in the arachidonic acid metabolites thromboxane and prostacyclin are known to contribute to hemodynamic changes observed in certain models of acute and chronic renal failure. We have previously shown that thromboxane may have an important role in mediating glomerulosclerosis by...

  • Estrogen-Progesterone Therapy for Bleeding Gastrointestinal Telangiectasias in Chronic Renal Failure. Bronner, Mark H.; Pate, Marion B.; Cunningham, John T.; Marsh, William H. // Annals of Internal Medicine;Sep86, Vol. 105 Issue 3, p371 

    Presents a study which utilized estrogen-progesterone therapy to treat a group of patients with chronic renal failure who had bleeding gastrointestinal telangiectasias. Information on gastrointestinal hemorrhage; Patients and methods; Results.

  • Estrogen induces glomerulosclerosis in analbuminemic rats. Joles, Jaap A.; van Goor, Harry; Koomans, Hein A. // Kidney International;Apr1998, Vol. 53 Issue 4, p862 

    Investigates the effect of estrogen treatment in hyperlipidemic analbuminemic rats (NAR). Prevalence of chronic renal disease among female NAR; Manifestation of hypercholesterolemia; Presentation of severe glomerular sclerosis among ovariectomized NAR.

  • Upper Gastrointestinal Bleeding in Patients with Chronic Renal Failure. Zuckerman, Gary r.; Cornette, Gary L.; Clouse, Ray E.; Harter, Herschel R. // Annals of Internal Medicine;May85, Vol. 102 Issue 5, p588 

    Presents information on a study which evaluated the upper gastrointestinal bleeding in patients with chronic renal failure using endoscopy procedures. Demographic characteristics of bleeding in patients with and without chronic renal failure; Methodology; Results and discussion.

  • Should Aspirin Therapy Be Withheld Before Insertion and/or Removal of a Permanent Peritoneal Dialysis Catheter? Shpitz, Baruch; Spindel, Zvi; Buklan, Genadi; Klein, Ehud; Plotkin, Eleanora; Bernheim, Jacques; Korzets, Ze'ev // American Surgeon;Sep2002, Vol. 68 Issue 9, p762 

    The necessity of withdrawal of aspirin [acetylsalicylic acid (ASA)] for fear of perioperative or postoperative bleeding in patients about to undergo surgery is as yet controversial. In this study we prospectively evaluated the effect of ASA on postoperative bleeding in end-stage renal failure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics